|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar
|
|
4
|
van Gijn W, Marijnen CA, Nagtegaal ID,
Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius
B and van de Velde CJ; Dutch Colorectal Cancer Group. Preoperative
radiotherapy combined with total mesorectal excision for resectable
rectal cancer: 12-year follow-up of the multicentre, randomised
controlled TME trial. Lancet Oncol. 12:575–582. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huerta S, Gao X and Saha D: Mechanisms of
resistance to ionizing radiation in rectal cancer. Expert Rev Mol
Diagn. 9:469–480. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huerta S, Hrom J, Gao X, Saha D, Anthony
T, Reinhart H and Kapur P: Tissue microarray constructs to predict
a response to chemoradiation in rectal cancer. Dig Liver Dis.
42:679–684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gérard JP, Azria D, Gourgou-Bourgade S,
Martel-Lafay I, Hennequin C, Etienne PL, Vendrely V, François E, de
La Roche G, Bouché O, et al: Clinical outcome of the ACCORD 12/0405
PRODIGE 2 randomized trial in rectal cancer. J Clin Oncol.
30:4558–4565. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bosset JF, Calais G, Mineur L, Maingon P,
Stojanovic-Rundic S, Bensadoun RJ, Bardet E, Beny A, Ollier JC,
Bolla M, et al; EORTC Radiation Oncology Group. Fluorouracil-based
adjuvant chemotherapy after preoperative chemoradiotherapy in
rectal cancer: Long-term results of the EORTC 22921 randomised
study. Lancet Oncol. 15:184–190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Steele FR, Chader GJ, Johnson LV and
Tombran-Tink J: Pigment epithelium-derived factor: Neurotrophic
activity and identification as a member of the serine protease
inhibitor gene family. Proc Natl Acad Sci USA. 90:1526–1530. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dawson DW, Volpert OV, Gillis P, Crawford
SE, Xu H, Benedict W and Bouck NP: Pigment epithelium-derived
factor: A potent inhibitor of angiogenesis. Science. 285:245–248.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Becerra SP and Notario V: The effects of
PEDF on cancer biology: Mechanisms of action and therapeutic
potential. Nat Rev Cancer. 13:258–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hong H, Zhou T, Fang S, Jia M, Xu Z, Dai
Z, Li C, Li S, Li L, Zhang T, et al: Pigment epithelium-derived
factor (PEDF) inhibits breast cancer metastasis by down-regulating
fibronectin. Breast Cancer Res Treat. 148:61–72. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guan M, Jiang H, Xu C, Xu R, Chen Z and Lu
Y: Adenovirus-mediated PEDF expression inhibits prostate cancer
cell growth and results in augmented expression of PAI-2. Cancer
Biol Ther. 6:419–425. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim KJ, Yun JH, Heo JI, Lee EH, Min HS,
Choi TH and Cho CH: Role of pigment epithelium-derived factor in
the involution of hemangioma: Autocrine growth inhibition of
hemangioma-derived endothelial cells. Biochem Biophys Res Commun.
454:282–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ek ET, Dass CR and Choong PF: PEDF: A
potential molecular therapeutic target with multiple anti-cancer
activities. Trends Mol Med. 12:497–502. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Manalo KB, Choong PF and Dass CR: Pigment
epithelium-derived factor as an impending therapeutic agent against
vascular epithelial growth factor-driven tumor-angiogenesis. Mol
Carcinog. 50:67–72. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Manalo KB, Choong PF, Becerra SP and Dass
CR: Pigment epithelium-derived factor as an anticancer drug and new
treatment methods following the discovery of its receptors: A
patent perspective. Expert Opin Ther Pat. 21:121–130. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu QJ, Gong CY, Luo ST, Zhang DM, Zhang S,
Shi HS, Lu L, Yan HX, He SS, Li DD, et al: AAV-mediated human PEDF
inhibits tumor growth and metastasis in murine colorectal
peritoneal carcinomatosis model. BMC Cancer. 12:1292012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cui FY, Song XR, Li ZY, Li SZ, Mu B, Mao
YQ, Wei YQ and Yang L: The pigment epithelial-derived factor gene
loaded in PLGA nanoparticles for therapy of colon carcinoma. Oncol
Rep. 24:661–668. 2010.PubMed/NCBI
|
|
20
|
Ji D, Li M, Zhan T, Yao Y, Shen J, Tian H,
Zhang Z and Gu J: Prognostic role of serum AZGP1, PEDF and PRDX2 in
colorectal cancer patients. Carcinogenesis. 34:1265–1272. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mandard AM, Dalibard F, Mandard JC, Marnay
J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G,
et al: Pathologic assessment of tumor regression after preoperative
chemoradiotherapy of esophageal carcinoma. Clinicopathologic
correlations. Cancer. 73:2680–2686. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Koumakpayi IH, Le Page C, Mes-Masson AM
and Saad F: Hierarchical clustering of immunohistochemical analysis
of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and
prognostic significance in prostate cancer. Br J Cancer.
102:1163–1173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cancer Genome Atlas Network. Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Croft D, Mundo AF, Haw R, Milacic M,
Weiser J, Wu G, Caudy M, Garapati P, Gillespie M, Kamdar MR, et al:
The Reactome pathway knowledgebase. Nucleic Acids Res.
42D:D472–D477. 2014. View Article : Google Scholar
|
|
25
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43D:D447–D452. 2015. View Article : Google Scholar
|
|
26
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES, et al: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Barretina J, Caponigro G, Stransky N,
Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV,
Sonkin D, et al: The Cancer Cell Line Encyclopedia enables
predictive modelling of anticancer drug sensitivity. Nature.
483:603–607. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Z, Fang S, Zuo Y, Zhang Y, Cheng R,
Wang Q, Yang Z, Cai W, Ma J, Yang X, et al: Combination of pigment
epithelium-derived factor with radiotherapy enhances the antitumor
effects on nasopharyngeal carcinoma by downregulating vascular
endothelial growth factor expression and angiogenesis. Cancer Sci.
102:1789–1798. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang L and Gu J: Risk factors for
symptomatic anastomotic leakage after low anterior resection for
rectal cancer with 30 Gy/10 f/2 w preoperative radiotherapy. World
J Surg. 34:1080–1085. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Stipa F, Chessin DB, Shia J, Paty PB,
Weiser M, Temple LK, Minsky BD, Wong WD and Guillem JG: A
pathologic complete response of rectal cancer to preoperative
combined-modality therapy results in improved oncological outcome
compared with those who achieve no downstaging on the basis of
preoperative endorectal ultrasonography. Ann Surg Oncol.
13:1047–1053. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Meimarakis G, Angele MK, Schneider C,
Weidenhagen R, Kalaitzis N, Molki A, Jauch KW, Hatz R and Winter H:
Impact of systematic lymph node dissection in the resection of
pulmonary metastases of solid extrapulmonary tumours. Zentralbl
Chir. 135:556–563. 2010.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen J, Ye L, Zhang L and Jiang WG: The
molecular impact of pigment epithelium-derived factor, PEDF, on
lung cancer cells and the clinical significance. Int J Oncol.
35:159–166. 2009.PubMed/NCBI
|
|
33
|
Yamaguchi H, Bhalla K and Wang HG: Bax
plays a pivotal role in thapsigargin-induced apoptosis of human
colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2
release from mitochondria. Cancer Res. 63:1483–1489.
2003.PubMed/NCBI
|
|
34
|
Dewhirst MW, Cao Y and Moeller B: Cycling
hypoxia and free radicals regulate angiogenesis and radiotherapy
response. Nat Rev Cancer. 8:425–437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bhadada SV, Goyal BR and Patel MM:
Angiogenic targets for potential disorders. Fundam Clin Pharmacol.
25:29–47. 2011. View Article : Google Scholar
|
|
36
|
Eefsen RL, Engelholm L, Willemoe GL, Van
den Eynden GG, Laerum OD, Christensen IJ, Rolff HC, Høyer-Hansen G,
Osterlind K, Vainer B, et al: Microvessel density and endothelial
cell proliferation levels in colorectal liver metastases from
patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
Int J Cancer. 138:1777–1784. 2016. View Article : Google Scholar
|
|
37
|
Yamada Y, Arao T, Matsumoto K, Gupta V,
Tan W, Fedynyshyn J, Nakajima TE, Shimada Y, Hamaguchi T, Kato K,
et al: Plasma concentrations of VCAM-1 and PAI-1: A predictive
biomarker for post-operative recurrence in colorectal cancer.
Cancer Sci. 101:1886–1890. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Baylin SB and Ohm JE: Epigenetic gene
silencing in cancer - a mechanism for early oncogenic pathway
addiction? Nat Rev Cancer. 6:107–116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ha YJ, Kim CW, Roh SA, Cho DH, Park JL,
Kim SY, Kim JH, Choi EK, Kim YS and Kim JC: Epigenetic regulation
of KLHL34 predictive of pathologic response to preoperative
chemoradiation therapy in rectal cancer patients. Int J Radiat
Oncol Biol Phys. 91:650–658. 2015. View Article : Google Scholar : PubMed/NCBI
|
